Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses
Authors
Keywords
Central nervous system, Glial cells, Neuroinflammation, Phytocannabinoids, Synthetic cannabinoids
Journal
Journal of Neuroimmune Pharmacology
Volume 10, Issue 2, Pages 268-280
Publisher
Springer Nature
Online
2015-01-19
DOI
10.1007/s11481-015-9584-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Microglia Development and Function
- (2014) Debasis Nayak et al. Annual Review of Immunology
- Cannabidiol enhances microglial phagocytosis via transient receptor potential (TRP) channel activation
- (2014) Samia Hassan et al. BRITISH JOURNAL OF PHARMACOLOGY
- Changes in Endocannabinoid Receptors and Enzymes in the Spinal Cord of SOD1G93ATransgenic Mice and Evaluation of a Sativex®-like Combination of Phytocannabinoids: Interest for Future Therapies in Amyotrophic Lateral Sclerosis
- (2014) Miguel Moreno-Martet et al. CNS Neuroscience & Therapeutics
- Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications
- (2014) Marisol S. Castaneto et al. DRUG AND ALCOHOL DEPENDENCE
- Breaking peripheral immune tolerance to CNS antigens in neurodegenerative diseases: Boosting autoimmunity to fight-off chronic neuroinflammation
- (2014) Michal Schwartz et al. JOURNAL OF AUTOIMMUNITY
- Histone Modifications Are Associated with Δ9-Tetrahydrocannabinol-mediated Alterations in Antigen-specific T Cell Responses
- (2014) Xiaoming Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cannabinoids Affect Dendritic Cell (DC) Potassium Channel Function and Modulate DC T Cell Stimulatory Capacity
- (2014) P. W. Wacnik et al. JOURNAL OF IMMUNOLOGY
- The Ground State of Innate Immune Responsiveness Is Determined at the Interface of Genetic, Epigenetic, and Environmental Influences
- (2014) E. Huang et al. JOURNAL OF IMMUNOLOGY
- Synthetic cannabinoids: Analysis and metabolites
- (2014) Mahmoud A. ElSohly et al. LIFE SCIENCES
- Microglial and macrophage polarization—new prospects for brain repair
- (2014) Xiaoming Hu et al. Nature Reviews Neurology
- Early phytocannabinoid chemistry to endocannabinoids and beyond
- (2014) Raphael Mechoulam et al. NATURE REVIEWS NEUROSCIENCE
- Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease
- (2014) Marco Prinz et al. NATURE REVIEWS NEUROSCIENCE
- Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies
- (2014) Mauro Maccarrone et al. NATURE REVIEWS NEUROSCIENCE
- Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology
- (2014) B. S. Koppel et al. NEUROLOGY
- Astrocyte Reactivity and Reactive Astrogliosis: Costs and Benefits
- (2014) Milos Pekny et al. PHYSIOLOGICAL REVIEWS
- Toll-Like Receptor Signaling Pathways
- (2014) Takumi Kawasaki et al. Frontiers in Immunology
- Gone to Pot – A Review of the Association between Cannabis and Psychosis
- (2014) Rajiv Radhakrishnan et al. Frontiers in Psychiatry
- Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis
- (2013) Valerio Chiurchiù et al. ANNALS OF NEUROLOGY
- Epigenetic control of skin differentiation genes by phytocannabinoids
- (2013) Mariangela Pucci et al. BRITISH JOURNAL OF PHARMACOLOGY
- Anti-inflammatory effects of cannabinoid CB2receptor activation in endotoxin-induced uveitis
- (2013) J T Toguri et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid Effects on β Amyloid Fibril and Aggregate Formation, Neuronal and Microglial-Activated Neurotoxicity In Vitro
- (2013) Emelie Janefjord et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS
- (2013) Weimin Kong et al. CELLULAR IMMUNOLOGY
- Amyloid-β Peptides, Alzheimer's Disease and the Blood-brain Barrier
- (2013) Fabien Gosselet et al. Current Alzheimer Research
- A Systematic Review of Pharmacological Pain Management in Multiple Sclerosis
- (2013) Rachel Jawahar et al. DRUGS
- Epigenetic mechanisms and endocannabinoid signalling
- (2013) Claudio D'Addario et al. FEBS Journal
- Microglial activation underlies cerebellar deficits produced by repeated cannabis exposure
- (2013) Laura Cutando et al. JOURNAL OF CLINICAL INVESTIGATION
- Immune Players in the CNS: The Astrocyte
- (2013) Cathy J. Jensen et al. Journal of Neuroimmune Pharmacology
- The Immune Pathogenesis of Multiple Sclerosis
- (2013) Robert Weissert Journal of Neuroimmune Pharmacology
- Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity
- (2013) Dimitris N. Xanthos et al. NATURE REVIEWS NEUROSCIENCE
- Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
- (2013) M. Mecha et al. NEUROBIOLOGY OF DISEASE
- Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation
- (2013) Ismael Galve-Roperh et al. PROGRESS IN LIPID RESEARCH
- Common non-epigenetic drugs as epigenetic modulators
- (2013) Jörn Lötsch et al. TRENDS IN MOLECULAR MEDICINE
- Origin and differentiation of microglia
- (2013) Florent Ginhoux et al. Frontiers in Cellular Neuroscience
- Potential Control of Multiple Sclerosis by Cannabis and the Endocannabinoid System
- (2012) Gareth Pryce et al. CNS & Neurological Disorders-Drug Targets
- A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis
- (2012) Aitor G. Granja et al. Journal of Neuroimmune Pharmacology
- Activation of Cannabinoid Receptor 2 Attenuates Leukocyte-Endothelial Cell Interactions and Blood-Brain Barrier Dysfunction under Inflammatory Conditions
- (2012) S. H. Ramirez et al. JOURNAL OF NEUROSCIENCE
- Chronic Inflammatory Disorders and Their Redox Control: From Molecular Mechanisms to Therapeutic Opportunities
- (2011) Valerio Chiurchiù et al. ANTIOXIDANTS & REDOX SIGNALING
- Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance
- (2011) M Maccarrone et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice
- (2011) Ewa Kozela et al. BRITISH JOURNAL OF PHARMACOLOGY
- Neuroprotective agents: Cannabinoids
- (2011) A.J. Sánchez et al. CLINICAL IMMUNOLOGY
- TRPV1 Signaling: Mechanistic Understanding and Therapeutic Potential
- (2011) Rong Xia et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease
- (2011) Sreemanti Basu et al. IMMUNOLOGIC RESEARCH
- Identification of the Synthetic CannabinoidR(+)WIN55,212-2 as a Novel Regulator of IFN Regulatory Factor 3 Activation and IFN-β Expression
- (2011) Eric J. Downer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inverse agonism of cannabinoid CB1 receptor blocks the adhesion of encephalitogenic T cells in inflamed brain venules by a protein kinase A-dependent mechanism
- (2011) Barbara Rossi et al. JOURNAL OF NEUROIMMUNOLOGY
- Anandamide inhibits Theiler's virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB1 receptors
- (2011) Leyre Mestre et al. Journal of Neuroinflammation
- Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease
- (2011) A. M. Martin-Moreno et al. MOLECULAR PHARMACOLOGY
- Cannabinoids and Innate Immunity: Taking a Toll on Neuroinflammation
- (2011) Eric J. Downer TheScientificWorldJOURNAL
- Cannabis and Amyotrophic Lateral Sclerosis: Hypothetical and Practical Applications, and a Call for Clinical Trials
- (2010) Gregory T. Carter et al. American Journal of Hospice & Palliative Medicine
- Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis
- (2010) Silvia Rossi et al. Amyotrophic Lateral Sclerosis
- Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington’s disease
- (2010) Cristina Blázquez et al. BRAIN
- CB2: a cannabinoid receptor with an identity crisis
- (2010) Brady K Atwood et al. BRITISH JOURNAL OF PHARMACOLOGY
- GPR55: Current Knowledge and Future Perspectives of a Purported “Type-3” Cannabinoid Receptor
- (2010) A. Moriconi et al. CURRENT MEDICINAL CHEMISTRY
- From Surface to Nuclear Receptors: The Endocannabinoid Family Extends its Assets
- (2010) M. Pistis et al. CURRENT MEDICINAL CHEMISTRY
- Cannabinoid CB2 Receptors in Health and Disease
- (2010) K. Patel et al. CURRENT MEDICINAL CHEMISTRY
- Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas
- (2010) Nephi Stella GLIA
- Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial
- (2010) M. Weber et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Huntington's disease: from molecular pathogenesis to clinical treatment
- (2010) Christopher A Ross et al. LANCET NEUROLOGY
- Molecular and clinical prodrome of Parkinson disease: implications for treatment
- (2010) Anthony H. V. Schapira et al. Nature Reviews Neurology
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
- (2010) R. G. Pertwee et al. PHARMACOLOGICAL REVIEWS
- Antidepressant-like effect of Δ9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.
- (2010) Abir T. El-Alfy et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Astrocytes: biology and pathology
- (2009) Michael V. Sofroniew et al. ACTA NEUROPATHOLOGICA
- WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease
- (2009) David A. Price et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment
- (2009) Sasidhar Murikinati et al. FASEB JOURNAL
- Differential changes in GPR55 during microglial cell activation
- (2009) Maciej Pietr et al. FEBS LETTERS
- Cannabinoids Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Inhibit the Lipopolysaccharide-activated NF-κB and Interferon-β/STAT Proinflammatory Pathways in BV-2 Microglial Cells
- (2009) Ewa Kozela et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cannabinoids prevent the opposite regulation of astroglial connexin43 hemichannels and gap junction channels induced by pro-inflammatory treatments
- (2009) Nicolas Froger et al. JOURNAL OF NEUROCHEMISTRY
- WIN55,212-2 Inhibits Production of CX3CL1 by Human Astrocytes: Involvement of p38 MAP Kinase
- (2009) W. S. Sheng et al. Journal of Neuroimmune Pharmacology
- Role of the innate immune system in the pathogenesis of multiple sclerosis
- (2009) Roopali Gandhi et al. JOURNAL OF NEUROIMMUNOLOGY
- Selective CB2 Receptor Agonism Protects Central Neurons from Remote Axotomy-Induced Apoptosis through the PI3K/Akt Pathway
- (2009) M. T. Viscomi et al. JOURNAL OF NEUROSCIENCE
- Low-Cost Travel in Neurons
- (2009) P. J. Magistretti SCIENCE
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
- A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules
- (2008) L. Mestre et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Genomic and proteomic analysis of the effects of cannabinoids on normal human astrocytes
- (2007) B. Bindukumar et al. BRAIN RESEARCH
- Cannabidiol in vivo blunts β-amyloid induced neuroinflammation by suppressing IL-1β and iNOS expression
- (2007) G Esposito et al. BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation